GSK invests in Varaha's regenerative agriculture carbon credits in northern India

GSK has entered an 8-year purchase agreement for carbon credits from Varaha's regenerative agriculture project in northern India, structured by Earthly. The biopharma company will support the expansion of regenerative agriculture practices across over 50,000 hectares, aiming to reduce crop residue burning and increase soil carbon storage. This investment aligns with GSK's sustainability strategy to reduce 80% of its CO2 emissions by 2030 and address the remaining 20% through high-quality nature projects. The project, certified under Verra's VM0042 methodology, will be upgraded to VM0042 v2.2, allowing future issuances to qualify for the CCP label.

This summary was written by carbon.fyi from the reporting linked above. It is not a quotation; cite the original source.